Recent Insider Transactions - Amicus Therapeutics (NASDAQ: FOLD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ FOLD Amicus Therapeutics

Rosenberg Ellen / officer: Chief Legal Officer

01/03/2025

Sell

$9.41

15,397

$145K

474,875

NASDAQ FOLD Amicus Therapeutics

Rosenberg Ellen / officer: Chief Legal Officer

01/04/2025

Sell

$9.41

3,381

$32K

471,494

NASDAQ FOLD Amicus Therapeutics

Rosenberg Ellen / officer: Chief Legal Officer

01/02/2025

Sell

$9.31

6,442

$60K

377,777

NASDAQ FOLD Amicus Therapeutics

Rosenberg Ellen / officer: Chief Legal Officer

01/03/2025

Buy

$9.41

203,825

$1.918M

203,825

NASDAQ FOLD Amicus Therapeutics

Prout Samantha / officer: Chief Accounting Officer

01/03/2025

Sell

$9.41

8,275

$78K

96,822

NASDAQ FOLD Amicus Therapeutics

Prout Samantha / officer: Chief Accounting Officer

01/04/2025

Sell

$9.41

1,297

$12K

95,525

NASDAQ FOLD Amicus Therapeutics

Prout Samantha / officer: Chief Accounting Officer

01/02/2025

Sell

$9.31

3,443

$32K

70,483

NASDAQ FOLD Amicus Therapeutics

Prout Samantha / officer: Chief Accounting Officer

01/03/2025

Buy

$9.41

62,715

$590K

62,715

NASDAQ FOLD Amicus Therapeutics

Clark David Michael / officer: Chief People Officer

01/03/2025

Sell

$9.41

11,987

$113K

319,208

NASDAQ FOLD Amicus Therapeutics

Clark David Michael / officer: Chief People Officer

01/04/2025

Sell

$9.41

2,692

$25K

316,516

NASDAQ FOLD Amicus Therapeutics

Clark David Michael / officer: Chief People Officer

01/02/2025

Sell

$9.31

5,381

$50K

261,967

NASDAQ FOLD Amicus Therapeutics

Clark David Michael / officer: Chief People Officer

01/03/2025

Buy

$9.41

125,430

$1.180M

125,430

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

01/03/2025

Sell

$9.41

41,474

$390K

1.09M

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

01/04/2025

Sell

$9.41

7,368

$69K

1.08M

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

01/02/2025

Sell

$9.31

20,647

$192K

866,007

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

01/03/2025

Buy

$9.41

482,908

$4.544M

482,908

NASDAQ FOLD Amicus Therapeutics

Castelli Jeff / officer: Chief Development Officer

01/03/2025

Sell

$9.41

14,299

$135K

438,989

NASDAQ FOLD Amicus Therapeutics

Castelli Jeff / officer: Chief Development Officer

01/04/2025

Sell

$9.41

3,127

$29K

435,862

NASDAQ FOLD Amicus Therapeutics

Castelli Jeff / officer: Chief Development Officer

01/02/2025

Sell

$9.31

6,990

$65K

370,215

NASDAQ FOLD Amicus Therapeutics

Castelli Jeff / officer: Chief Development Officer

01/03/2025

Buy

$9.41

150,517

$1.416M

150,517

NASDAQ FOLD Amicus Therapeutics

Harford Simon N.R. / officer: Chief Financial Officer

01/03/2025

Buy

$9.41

150,517

$1.416M

150,517

NASDAQ FOLD Amicus Therapeutics

Harford Simon N.R. / officer: Chief Financial Officer

01/02/2025

Sell

$9.31

7,482

$70K

144,354

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

12/02/2024

Buy

$8.61

7,500

$65K

894,154

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

12/02/2024

Sell

$10.02

7,500

$75K

886,654

NASDAQ FOLD Amicus Therapeutics

Campbell Bradley L / director, officer: President and CEO

12/02/2024

Sell

$8.61

7,500

$65K